The project, more than a decade in the making, replaces a business campus that was once home to Johnson & Johnson, Pfizer and ...

Merck is particularly exposed to the tariff threat, as much of its production of Keytruda takes place at facilities in ...

President Trump’s proposed 25% tariff on pharmaceutical imports, largely from Ireland, could raise U.S. drug costs by nearly ...

People have built some amazing things, but sometimes our architectural ambitions have outpaced our resources or abilities.

The Michigan State Board of Trustees voted to approve the construction of a new major project, called “The ... ability to remain competitive in the Big Ten Conference. Despite the approval ...

The satellite imagery reveals key indicators of real-world development: large-scale earthworks, completed buildings, ...

Three large NGOs signalled concern on Monday that Big Pharma is seeking to impact reforms of the EU drug framework by persuading the European Commission to introduce new incentives to support ...

Roche RHHBY, based in Basel, Switzerland, is the latest pharma company to announce a big investment in the ... Carolina to support 5,000 jobs during construction. Jeff Jonas, portfolio manager ...

Analysts casting their eyes forward to 2022 see big pharma maintaining its position in the sector, protected by vast war chests and ready to pounce on any newcomer that shows promise. In the ...

The last few years have been marked by many big pharma companies opting to move away from diversification and towards more focused operations. Ben Hargreaves explores what is driving this ...